Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03793140
Recruitment Status : Recruiting
First Posted : January 4, 2019
Last Update Posted : November 17, 2020
Sponsor:
Collaborators:
City of Hope Medical Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
George Washington University
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021